EP1692128 - INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.10.2009 Database last updated on 12.07.2024 | Most recent event Tooltip | 09.10.2009 | Application deemed to be withdrawn | published on 11.11.2009 [2009/46] | Applicant(s) | For all designated states Signal Pharmaceuticals LLC 4550 Towne Centre Court San Diego, CA 92121 / US | [2006/34] | Inventor(s) | 01 /
BHAGWAT, Shripad, S. 5015 Ashley Falls Court San Diego, CA 92130 / US | 02 /
SATOH, Yoshitaka 11460 Larmier Circle San Diego, CA 92131 / US | 03 /
SAKATA, Steven, T. 5290 Timber Branch Way San Diego, CA 92130 / US | 04 /
BUHR, Chris, A. 355 Belmont Avenue Redwood City, CA 94061 / US | 05 /
ALBERS, Ronald 6559 Comly Street San Diego, CA 94111 / US | 06 /
SAPIENZA, John 1654 Ridge Rock Court Chula Vista, CA 91913 / US | 07 /
PLANTEVIN, Veronique 11045 Alonda Court San Diedo, CA 92126 / US | 08 /
CHAO, Qi 7696 Marker Road San Diego, CA 92130 / US | 09 /
SAHASRABUDHE, Kiran 9820 Reagan Road, Apt. 210 San Diego, CA 92126 / US | 10 /
FERRY, Rachel 2011 Polk Avenue San Diego, CA 92104 / US | 11 /
NARLA, Rama, K. 8246 Bryn Glen Way San Diego, CA 92129 / US | [2006/39] |
Former [2006/34] | 01 /
BHAGWAT, Shripad, S. 5015 Ashley Falls Court San Diego, CA 92130 / US | ||
02 /
SATOH, Yoshitaka 11460 Larmier Circle San Diego, CA 92131 / US | |||
03 /
SAKATA, Steven, T. 5290 Timber Branch Way San Diego, CA 92130 / US | |||
04 /
BUHR, Chris, A. 355 Belmont Avenue Redwood City, CA 94061 / US | |||
05 /
ALBERS, Ronald 6559 Comly Street San Diego, CA 94111 / US | |||
06 /
SAPIENZA, John 1654 Ridge Rock Court Chula Vista, CA 91913 / US | |||
07 /
PLANTEVIN, Veronique 11045 Alonda Court San Diedo, CA 92126 / US | |||
08 /
CHAO, Qi 12604 Torrey Bluff Drive San Diego, CA 92130 / US | |||
09 /
SAHASRABUDHE, Kiran 9820 Reagan Road, Apt. 210 San Diego, CA 92126 / US | |||
10 /
FERRY, Rachel 4385 Georgia Street, 6 San Diego, CA 92103 / US | |||
11 /
NARLA, Rama, K. 8246 Bryn Glen Way San Diego, CA 92129 / US | Representative(s) | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | [N/P] |
Former [2006/34] | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | Application number, filing date | 04811774.1 | 19.11.2004 | [2006/34] | WO2004US39113 | Priority number, date | US20030608929P | 19.11.2003 Original published format: US 608929 P | [2006/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005051942 | Date: | 09.06.2005 | Language: | EN | [2005/23] | Type: | A1 Application with search report | No.: | EP1692128 | Date: | 23.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.06.2005 takes the place of the publication of the European patent application. | [2006/34] | Search report(s) | International search report - published on: | EP | 09.06.2005 | Classification | IPC: | C07D403/04, C07D401/14, C07D403/14, C07D403/12, A61K31/416, A61K31/4196 | [2006/34] | CPC: |
C07D403/12 (EP,US);
A61P1/04 (EP);
A61P11/00 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
C07D401/14 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/34] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | INDAZOLVERBINDUNGEN UND VERFAHREN ZU DEREN ANWENDUNG ALS PROTEINKINASEINHIBITOREN | [2006/34] | English: | INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF AS PROTEIN KINASE INHIBITORS | [2006/34] | French: | COMPOSES D'INDAZOLE ET LEURS PROCEDES D'UTILISATION EN TANT QU'INHIBITEURS DE LA PROTEINE KINASE | [2006/34] | Entry into regional phase | 14.06.2006 | National basic fee paid | 14.06.2006 | Designation fee(s) paid | 14.06.2006 | Examination fee paid | Examination procedure | 10.06.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 14.06.2006 | Examination requested [2006/34] | 03.08.2006 | Amendment by applicant (claims and/or description) | 28.06.2007 | Despatch of a communication from the examining division (Time limit: M04) | 02.11.2007 | Reply to a communication from the examining division | 10.09.2008 | Date of oral proceedings | 10.12.2008 | Minutes of oral proceedings despatched | 12.12.2008 | Communication of intention to grant the patent | 23.04.2009 | Application deemed to be withdrawn, date of legal effect [2009/46] | 02.06.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2009/46] | Divisional application(s) | EP08015782.9 Application deemed to be withdrawn : 09.10.2008 | EP08022584.0 / EP2065383 | Fees paid | Renewal fee | 14.11.2006 | Renewal fee patent year 03 | 15.11.2007 | Renewal fee patent year 04 | 27.11.2008 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX]WO2004094388 (SIGNAL PHARM LLC [US], et al) [PX] 1-106 * claims 1,3,7-9,14,17,18,22,23,6-36,40-42,47,50,51; compounds 188,190,408,409 *; | [Y]WO03004488 (CHIRON CORP [US], et al) [Y] 1-106 * claims 1-71 *; | [XD]WO0210137 (SIGNAL PHARM INC [US], et al) [XD] 1-106 * claims 1-3,8,9,14,17,18,5-32,37,38,43,46,47,50-52; compounds 188,190,408,409 *; | [Y]WO0102369 (AGOURON PHARMA [US]) [Y] 1-106 * claims 1-17 * |